关注
Boris Reva
Boris Reva
Computation Biology Center, Memorial Sloan-Kettering Cancer Center
在 cbio.mskcc.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data
E Cerami, J Gao, U Dogrusoz, BE Gross, SO Sumer, BA Aksoy, ...
Cancer discovery 2 (5), 401-404, 2012
147242012
Comprehensive molecular portraits of human breast tumours
Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
111352012
Comprehensive molecular characterization of human colon and rectal cancer
Cancer Genome Atlas Network
Nature 487 (7407), 330, 2012
74802012
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
CGAR Network
nature 455, 1061-8, 2008
73812008
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
68932011
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
cell 155 (2), 462-477, 2013
49802013
Integrated genomic characterization of endometrial carcinoma
DA Levine, ...
Nature 497 (7447), 67-73, 2013
49022013
Integrative genomic profiling of human prostate cancer
BS Taylor, N Schultz, H Hieronymus, A Gopalan, Y Xiao, BS Carver, ...
Cancer cell 18 (1), 11-22, 2010
40572010
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
36762012
Comprehensive molecular characterization of clear cell renal cell carcinoma
Cancer Genome Atlas Research Network Analysis working group: Baylor College ...
Nature 499 (7456), 43-49, 2013
28302013
Comprehensive molecular characterization of urothelial bladder carcinoma
Cancer Genome Atlas Research Network
Nature 507 (7492), 315, 2014
26242014
Predicting the functional impact of protein mutations: application to cancer genomics
B Reva, Y Antipin, C Sander
Nucleic acids research 39 (17), e118-e118, 2011
21572011
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
J Barretina, BS Taylor, S Banerji, AH Ramos, M Lagos-Quintana, ...
Nature genetics 42 (8), 715-721, 2010
7892010
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21. 1 losses in malignant pleural mesothelioma
M Bott, M Brevet, BS Taylor, S Shimizu, T Ito, L Wang, J Creaney, RA Lake, ...
Nature genetics 43 (7), 668-672, 2011
7782011
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2: 401–404
E Cerami, J Gao, U Dogrusoz, BE Gross, SO Sumer, BA Aksoy, ...
6882012
p53 regulates hematopoietic stem cell quiescence
Y Liu, SE Elf, Y Miyata, G Sashida, Y Liu, G Huang, S Di Giandomenico, ...
Cell stem cell 4 (1), 37-48, 2009
6352009
A specificity map for the PDZ domain family
R Tonikian, Y Zhang, SL Sazinsky, B Currell, JH Yeh, B Reva, HA Held, ...
PLoS biology 6 (9), e239, 2008
5632008
EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics
ME Arcila, K Nafa, JE Chaft, N Rekhtman, C Lau, BA Reva, MF Zakowski, ...
Molecular cancer therapeutics 12 (2), 220-229, 2013
4882013
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ...
Cell 182 (1), 200-225. e35, 2020
4772020
Integrated proteogenomic characterization of clear cell renal cell carcinoma
DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ...
Cell 179 (4), 964-983. e31, 2019
4652019
系统目前无法执行此操作,请稍后再试。
文章 1–20